[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337077-105":59,"doc-detail-337077-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hmga2-as-a-prognostic-and-immune-biomarker-in-hepatocellular-carcinoma-comprehensive-analysis-of-the-hmg-family-and-experiments-validation","HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma - Comprehensive analysis of the HMG family and experiments validation","","Molecular mechanisms driving hepatocellular carcinoma (HCC) remain incompletely understood, motivating this study of High Mobility Group (HMG) proteins for prognostic biomarkers and therapeutic targets. Bioinformatic analyses used The Cancer Genome Atlas (TCGA) and other databases. HMG expression was validated in HCC cell lines with qRT-PCR, and HMGA2 was functionally tested by knockdown. HMGA1, HMGA2, HMGB2, and HMGN1 were upregulated in HCC and linked to poor overall and disease-specific survival. HMGA2 knockdown reduced proliferation, migration, and invasion, supporting HMGA2’s biomarker and target potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hmga2-as-a-prognostic-and-immune-biomarker-in-hepatocellular-carcinoma-comprehensive-analysis-of-the-hmg-family-and-experiments-validation/337077/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hmga2-as-a-prognostic-and-immune-biomarker-in-hepatocellular-carcinoma-comprehensive-analysis-of-the-hmg-family-and-experiments-validation/337077.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main goal regarding HMGA2 and HCC?","Question",{"text":112,"@type":113},"To explore HMG protein expression and clinical significance in HCC to identify potential prognostic biomarkers and therapeutic targets, including HMGA2.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets and experimental methods were used?",{"text":117,"@type":113},"Bioinformatic analyses used TCGA and other databases, while HMG expression in HCC cell lines was validated using qRT-PCR and HMGA2 function was tested by knockdown.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship was observed between HMG protein levels and patient outcomes?",{"text":121,"@type":113},"Higher expression levels of HMG proteins were associated with poor overall survival and disease-specific survival in HCC patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337077,1791132808,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","PLOS ONE  \nOPEN ACCESS  \nCitation: Zhong Q, Zhao B, She X, Liu X (2024) HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma: Comprehensive analysis of the HMG family and experiments validation. PLoS ONE 19(11): e0311204 . [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1371/journal.pone](10.1371/journal.pone).0311204  \nEditor: Xiaosheng Tan, Rutgers: Rutgers The State University of New Jersey, UNITED STATES OF AMERICA  \nReceived: July 22, 2024  \nAccepted: September 15, 2024  \nPublished: November 26, 2024  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal.pone.031](https://doi.org/10.1371/journal.pone.031)1204  \nCopyright: © 2024 Zhong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: The datasets  \ngenerated from The TCGA database ([https://portal](https://portal). [gdc.cancer.gov](gdc.cancer.gov)) and GTEx database ([https://](https://)  \nRESEARCH ARTICLE  \nHMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma:  \nComprehensive analysis of the HMG family and experiments validation  \nQiangqiang Zhong1,2☯, Baokang Zhao1,3☯, Xiao She4, Xiangjie Liu3,5 *  \n1 Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China, 2 Laboratory of Metabolic Abnormalities and Vascular Aging Huazhong University of Science and Technology, Wuhan, PR China, 3 Department of Geriatrics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China, 4 Department of Gastroenterology, Xi’an Jiaotong University Second Affiliated Hospital, Xi’an, PR China, 5 Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China  \n☯ These authors contributed equally to this work.  \n* [liuxiangjie1968@126.com](liuxiangjie1968@126.com)  \nAbstract  \nThe molecular mechanisms underlying hepatocellular carcinoma (HCC) are complex and not fully understood. This study aims to explore the expression and clinical significance of High Mobility Group (HMG) proteins in HCC to identify potential prognostic biomarkers and therapeutic targets. Bioinformatic analyses were performed using data from The Cancer Genome Atlas (TCGA) and other databases. Expression levels of HMGs were validated in HCC cell lines using qRT-PCR, and functional studies were conducted by knocking down HMGA2 . HMG family members, particularly HMGA1, HMGA2, HMGB2, and HMGN1, were significantly upregulated in HCC tissues compared to normal tissues. High expression levels of these proteins were associated with poor overall survival and disease-specific survival in HCC patients. Knockdown of HMGA2 in HCC cell lines led to reduced cell proliferation , migration, and invasion. HMGA2, along with other HMG family members, emerges as a potential prognostic biomarker and therapeutic target in HCC. This study provides new insights into the role of HMG proteins in HCC progression.  \nIntroduction  \nLiver cancer stands out as one of the prevailing malignancies, witnessing around 90,600 fresh cases and nearly 830,000 associated fatalities in 2020. It holds the sixth position among the most frequent cancer types and claims the third spot for global cancer-linked mortalities [ 1] . HCC is a complex malignancy influenced by both environmental and dietary factors, and the precise molecular pathogenesis remains incompletely understood. While advancements in liver cancer treatment have le","cbCaiiduJYDHrQ18","https://ap.wps.com/l/cbCaiiduJYDHrQ18","pdf",8039318,26,"English","## Abstract\n## Introduction","[{\"question\":\"What is the study’s main goal regarding HMGA2 and HCC?\",\"answer\":\"To explore HMG protein expression and clinical significance in HCC to identify potential prognostic biomarkers and therapeutic targets, including HMGA2.\"},{\"question\":\"Which datasets and experimental methods were used?\",\"answer\":\"Bioinformatic analyses used TCGA and other databases, while HMG expression in HCC cell lines was validated using qRT-PCR and HMGA2 function was tested by knockdown.\"},{\"question\":\"What relationship was observed between HMG protein levels and patient outcomes?\",\"answer\":\"Higher expression levels of HMG proteins were associated with poor overall survival and disease-specific survival in HCC patients.\"}]","HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma - Comprehensive analysis of the HMG family and experiments validation | PDF",1790017639,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9c3b1d067a5e67c31736b7f772e4a8e.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38ac9dfc98b910cfe91c7c58257fadb4.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2027e019bc1881ca04b56ddabecb7c98.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1aa89496ecc7500e4e06d278ddb104fe.webp",980,1268]